SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-027585
Filing Date
2024-03-07
Accepted
2024-03-07 07:09:07
Documents
13
Period of Report
2024-03-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alks-20240305.htm   iXBRL 8-K 53558
2 EX-99.1 alks-ex99_1.htm EX-99.1 19335
  Complete submission text file 0000950170-24-027585.txt   199694

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alks-20240305.xsd EX-101.SCH 30799
15 EXTRACTED XBRL INSTANCE DOCUMENT alks-20240305_htm.xml XML 4683
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 24728140
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)